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2 
Introduction 25 
 26 
The relevance of two–dimensional cell cultures for increasing our understanding of tumour 27 
growth has been called into question 1,2. A promising alternative involves the growth of 28 
multicellular cancer spheroids in bioengineered microenvironments enabling a three–29 
dimension (3D) architecture, which more accurately reflects the in vivo situation than two–30 
dimensional assays. In particular, early events of tumour growth, before effective 31 
vascularisation, appear to be closely reproduced in such 3D culture systems. The proliferation 32 
of tumour cells cultured in three dimensions is typically slower, and hence, more 33 
physiological than that of traditional monolayer cultures 3. From a clinical point of view, it is 34 
important that the growth of cancer cells in 3D as multicellular spheroids confers on them a 35 
significant reduction in drug sensitivity and response to radiation when compared to cell 36 
monolayers 4,5. Culture models which maintain spheroids in suspension or embedded within 37 
naturally–derived matrices, such as laminin–rich matrices purified from animal tumours and 38 
rat tail collagens, have long been used to study the responses of tumour cells to exposure to 39 
nutrients, growth factors and/or anti–cancer drugs 6. These naturally–derived matrices have 40 
considerably advanced our knowledge of the fundamental interplay between cells and their 41 
extracellular microenvironment. However, there is wide consensus that these matrices exhibit 42 
some limitations and drawbacks. Their composition varies from batch to batch affecting 43 
experimental reproducibility 7, and their biochemical or biophysical characteristics are not 44 
easily accessible to modification. To overcome these limitations, the cancer biology 45 
community is increasingly seeking alternative 3D models that better replicate the tumour 46 
microenvironment 1. Our group employs technology platforms originally developed for tissue 47 
engineering applications to design models that mimic tissue organization and, as such, can be 48 
used to enhance the understanding of cell/tissue function under pathological situations, such 49 
3 
as cancer. 50 
In this study, a 3D model was used to replicate cell–extracellular matrix (ECM) interactions 51 
that occur during the formation of multicellular cancer spheroids, similar to those found in 52 
ascites fluid which accumulates in the peritoneal cavity of patients diagnosed with advanced 53 
ovarian cancer 3,8. The role of integrin receptors in spheroid formation and proliferation of 54 
ovarian cancer cells has been described before 9,10. Integrin α6 is present in epithelial ovarian 55 
tumours and highly expressed in ovarian cancer cell lines, and its inhibition prevents cell 56 
proliferation 9. Our experimental 3D work involved the application of biomimetic hydrogels 57 
of varying stiffness to grow multicellular cancer spheroids from single cell suspensions 58 
encapsulated within these microenvironments for up to 28 days. Immunohistochemistry was 59 
used to quantify the dependence of cell proliferation and apoptosis on matrix stiffness, long–60 
term culture and treatment with the anti–cancer drug paclitaxel, an anti–proliferative, 61 
cytotoxic drug that stabilizes microtubules of cells 11. Multiple imaging techniques, such as 62 
confocal laser scanning, transmission electron, scanning electron, and time–lapse 63 
microscopy, were used to collect additional experimental data to estimate the parameters in a 64 
complementary mathematical model of tumour spheroid growth. The experimental results 65 
supported the mathematical modelling of the cancer spheroid behaviour in this bioengineered 66 
microenvironment. 67 
Mathematical modelling of cancer spheroid development and growth in vitro is a well–68 
established research area 12. While mathematical models can be used to test hypotheses and 69 
generate insights that would not otherwise be possible, when designed in isolation, they are 70 
unlikely to provide biological insight. The form of our mathematical model was motivated by 71 
our experimental data, which were also used to estimate key model parameters. The validated 72 
model parameter was then used to predict the outcome of experiments that were not 73 
conducted. In doing so, it is illustrated how mathematical models can be combined with 74 
4 
experimental data to enhance understanding of biological systems and to generate new, 75 
testable predictions. 76 
77 
5 
Materials and Models 78 
 79 
Three–dimensional cell culture models. Synthetic hydrogel biomaterials were prepared 80 
from peptide–functionalised multiarm polyethylene glycol (PEG) macromolecules as 81 
described by Ehrbar et al. 13. Briefly, the matrix stiffness was regulated by changing the 82 
polymer dry mass of the hydrogel (elastic shear modulus G’ = 241 ± 19, 637 ± 93, 1201 ± 83 
121 Pa), without changing its biochemical characteristics conferring biomimetic features 3. 84 
The mechanical properties of the hydrogel were reported previously 14. The human epithelial 85 
ovarian carcinoma cell line OV–MZ–6 was established from malignant ascites and cultured 86 
as described earlier 3. For three–dimensional (3D) cell cultures, ovarian cancer cells were 87 
encapsulated within PEG–based hydrogel and cultured for up to 28 days to form multicellular 88 
spheroids. For exposure to paclitaxel, a microtubule–stabilizing agent that mediates cell cycle 89 
arrest and apoptosis 15, cancer cell spheroids were grown for 7 days and then treated with 90 
paclitaxel–containing media (10 nmol/L) for another 7 days replenished every two days. 91 
Details of the materials, 3D cultures, immunohistochemistry staining, confocal laser scanning 92 
microscopy, scanning electron, transmission electron and time–lapse microscopy, calculation 93 
of cell area and statistical analyses are provided in the supplementary methods. 94 
 95 
Mathematical model. A mathematical model was used to simulate spheroid growth under 96 
conditions of different matrix stiffness, culture time and anti–cancer treatment. The 97 
experimental work informed the theoretical work; the mathematical model being constructed 98 
to be as simple as possible to incorporate the available data. An incompressible porous 99 
medium (IPM) model was developed using an approach originally proposed by Greenspan 16 100 
and adapted by others 17-19. The spheroid was viewed as a radially–symmetric ball of cells, 101 
6 
with radius ( )R t  at time t. Following the derivation in the supplementary material, the 102 
following differential equation for pressure (p(r,t)) at time t and spatial radius r was obtained 103 
 2 1 22
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where 1s  and 2s  are constant and linear coefficients associated with the net growth rate, and 105 
k  is the ratio of the cells’ permeability to their dynamic viscosity. The outer spheroid radius 106 
( )R t  wass assumed to move with the local cell velocity (v(R(t),t)) 107 
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where 0R  is the initial spheroid size and   the shear modulus of the hydrogel. 112 
 113 
Treatment with paclitaxel. The inhibitory effect of exposure to paclitaxel 15 was incorporated 114 
by assuming that the net growth rate coefficient was permanently reduced to 0s ( 0 1s s ) 115 
following treatment which, as in the experimental setup, started at t=7 days. Consequently, in 116 
equation (1) the constant 1s  was replaced by the function 1,mod ( )s t  117 
 11,mod
0
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 (4) 118 
More complex functional forms for 1,mod ( )s t  can be employed; for example, if the 119 
effectiveness of paclitaxel decreases over time, then the net growth rate coefficient might be 120 
assumed to return to its pre–treatment value, 1s , at long times (e.g. after about 30 days). 121 
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 122 
Mathematical analysis of the IPM model for growth of a control (non–treated) multicellular 123 
spheroid. The mathematical model can be reduced to the following ordinary differential 124 
equation (ODE) for the spheroid radius ( )R t  125 
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where 
0
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R
  . This equation can be fit to data showing how spheroid radii changes over 127 
time (and as the stiffness of the hydrogel in which they grow changes), in order to estimate 128 
the model parameters (details are provided in the supplementary methods). 129 
 130 
Parameter values and estimation. The model contained 8 parameters: 1s  and 0s  are, 131 
respectively, the constant coefficients associated with the net growth rate of the control and 132 
paclitaxel-treated spheroids (see equations (1) and (4)), 2s  is the corresponding linear 133 
coefficient, 0R  is the initial radius of the spheroid, 1 , 2 , 3  are the shear moduli of the 134 
three hydrogels of increasing stiffness (G’ = 241 ± 19, 637 ± 93, 1201 ± 121 Pa), and k  is the 135 
ratio of the cells’ permeability to their dynamic viscosity. k  was estimated to be 136 
191.2 10k    m3 day/kg 20. The other 7 parameters were estimated by performing Markov 137 
Chain Monte Carlo simulations, given dynamic data showing how the observed spheroid 138 
radii change over time (details are provided in the supplementary methods). 139 
140 
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Results 141 
 142 
Spheroid size in response to stiffness of the microenvironment 143 
In order to determine the stress–dependent growth and size of multicellular cancer spheroids 144 
embedded within biomimetic hydrogels, the mechanical stress component represented as 145 
microenvironmental stiffness was varied, by altering the polymer dry mass, from stiff [2.5% 146 
(w/v); this corresponds to G’ = 1201 ± 121 Pa 3], to medium stiff [2.0% (w/v); this 147 
corresponds to G’ = 637 ± 93 Pa 3] and soft [1.5% (w/v); this corresponds to G’ = 241 ± 19 148 
Pa 3]. Smaller, more compact spheroids were formed in stiffer hydrogels, whereas larger and 149 
less compact spheroids grew in softer hydrogels (Figure 1A, B). The proliferative behaviour 150 
also changed with increasing stiffness. The growth of multicellular spheroids was 151 
significantly reduced due to enhanced stiffness (Figure 1C). Spheroids grown in stiff 152 
hydrogels showed weak immunofluorescent staining for integrin α6 and Ki67, suggesting low 153 
expression of these proliferative markers, no expression of the apoptotic markers caspase–3 154 
and caspase–8, and only weak expression of annexin V near the outer spheroid radius were 155 
detected. In contrast, spheroids grown in soft hydrogels showed strong integrin α6 156 
expression, a distinct Ki67 signal, consistent with cells undergoing division, in the spheroid 157 
centre, and a more pronounced apoptotic signal as indicated by cytoplasmic caspase–8 158 
staining near the spheroid periphery (Figure 1D; S1; S2). 159 
The surface area of the spheroids was inversely correlated with the stiffness of the hydrogels: 160 
significantly smaller spheroids were formed in stiffer hydrogels than medium stiff or soft 161 
ones (Figure 1E). Moreover, time–lapse microscopy of live cell spheroid survival and 162 
formation over 4.5 days in microenvironments of different stiffnesses revealed that 163 
multicellular spheroids were formed from single cells, thereby confirming 164 
immunofluorescent and H/E imaging results (Figure S3; S4). 165 
9 
The time evolution of the outer radius of spheroids embedded in the three hydrogel 166 
stiffnesses was simulated using the mathematical model over a period of 5 days (Figure 1F). 167 
The IPM model predicted that stiffer microenvironments yield smaller spheroids, results 168 
which are in good agreement with the experimental data (Figure 1A–E; S2; S3; S4). The 169 
median spheroid radius at 4 days (90% confidence interval) was 25.9 (25.4, 26.7), 23.8 (23.3, 170 
24.2) and 20.1 (19.4, 20.8), respectively, in the soft (G’ = 241 ± 19 Pa), medium stiff (G’ = 171 
637 ± 93 Pa) and stiff (G’ = 1201 ± 121 Pa) hydrogels. 172 
For subsequent analyses, and based on estimates of the proliferation rates obtained using a 173 
different cancer cell line within the same bioengineered microenvironments 21, medium stiff 174 
(G’ = 637 ± 93 Pa) hydrogels were chosen as an optimal 3D culture system for the ovarian 175 
cancer spheroids used in our study. 176 
 177 
Spheroid size in response to culture time 178 
In the bioengineered microenvironments, spheroids grew significantly in size from 14 to 28 179 
days, with radii increasing from 38 ± 4 µm to 70 ± 6 µm (Figure 2A). A distinctive integrin 180 
α6 expression pattern was observed in the spheroid centre after 14 days, which was more 181 
pronounced after 28 days, and indicative of continuous proliferation rates and survival within 182 
the multicellular spheroids. These spheroids are similar to those found in the ascites fluid that 183 
accumulates in the peritoneal cavity of patients with advanced ovarian cancer 8. Caspase–8 184 
expression was negligible in spheroids grown for 14 days, but detected throughout spheroids 185 
cultured for 28 days, indicating that the rates of apoptosis increased with spheroid size 186 
(Figure 3A). The rate of cell proliferation increased over the monitored time frame of 28 days 187 
(Figure 2B). The surface area of the spheroids correlated with the culture time (Figure 2C). 188 
The IPM model was used to simulate the effect of long–term 3D culture in medium stiff (G’ 189 
= 637 ± 93 Pa) hydrogels and predicted a continual increase in spheroid size over 28 days 190 
10 
(Figure 2D). The mathematical model was fit to the experimental data (Figure 2A–C) and 191 
previous long–term 3D culture results 3, and in doing so, model parameters were estimated , 192 
resulting in an outer spheroid radii at 14 days of 42.4 µm (90% confidence interval: 36.7–193 
45.6), and 51.6 µm (90% confidence interval: 40.5–59.4) at 28 days. The predicted 194 
equilibrium spheroid radii (90% confidence interval) within the three hydrogels of increasing 195 
stiffnesses were 283.5 (124.9, 353.8), 55.0 (41.2, 68.0) and 24.9 (22.8, 27.6; Figure 2D). 196 
Both, experimental and modelling data showed at least a 22% increase in spheroid radii upon 197 
28 days culture time. 198 
 199 
Spheroid size in response to anti–cancer treatment 200 
Enhanced cancer spheroid resistance to chemotherapeutics has been observed in patients 201 
diagnosed with late stage ovarian cancer 8. We examined the chemoresistance of ovarian 202 
cancer cells grown as multicellular spheroids to a clinically–used anti–cancer agent, 203 
paclitaxel, which stabilizes microtubule, thereby mediating cell cycle arrest and apoptosis 15. 204 
Ovarian cancer cells were grown for 7 days in biomimetic hydrogels to allow multicellular 205 
spheroid formation. The spheroids were then treated with paclitaxel for another 7 days before 206 
assessment of cell survival and apoptotic markers was performed. Exposure to paclitaxel led 207 
to the formation of more spheroids, although they were smaller in size (radii 23 ± 3 µm) 208 
compared to the non–treated spheroids (radii 37 ± 5 µm; Figure 3A). Treatment with 209 
paclitaxel induced high levels of caspase–8 compared to non–treated cells, indicating 210 
enhanced apoptosis and cell death in the treated spheroids (Figure 3A). The proliferation rate 211 
of the multicellular spheroids was also reduced significantly (Figure 3B). Moreover, exposure 212 
to paclitaxel caused significant shrinkage of the total spheroid area [Figure 3C(i)], whereas 213 
the overall area of individual cells [Figure 3C(ii)] significantly increased, and the size of their 214 
nuclei [Figure 3C(iii)] was enlarged compared to non–treated conditions. 215 
11 
Ultrastructural differences between control and paclitaxel–treated spheroids were detected by 216 
transmission electron microscopy. In contrast, no major morphological changes between our 217 
3D and monolayer (two–dimensional) cultures of cancer cells were observed in previous 218 
studies 3,22. Spheroids showed compact cell organization, and cells within spheroids were 219 
partially separated by intercellular spaces bridged by cytoplasmic interdigitations and 220 
adherent junctions. In the cytoplasm, mitochondria, rough endoplasmatic reticulum and golgi 221 
apparatus were observed. The nuclei were moderately irregular in shape and encompassed 222 
more than half of the cell organelle. Upon paclitaxel treatment, mainly necrotic areas and 223 
smaller cell spheroids were found (Figure 3D). 224 
The IPM model predicted diverging spheroid radii in non–treated (shown in red) and treated 225 
(shown in blue) conditions after treatment starting on day 7 (Figure 3E). The spheroid radius 226 
at 14 days was 25.5 µm (90% confidence interval: 21.2–32.6) compared to 42.4 µm (90% 227 
confidence interval: 36.7–45.6 µm) without treatment in medium stiff (G’ = 637 ± 93 Pa) 228 
hydrogels [Figure 3E(i)]. The mathematical model was also used to predict the response of 229 
spheroids grown in soft [G’ = 241 ± 19 Pa; Figure 3E(ii)] and stiff stiff [G’ = 1201 ± 121 Pa; 230 
Figure 3E(iii)] hydrogels to treatment with same dose of paclitaxel, basing our predictions on 231 
data from spheroids treated with paclitaxel in medium stiff hydrogel. Both the experimental 232 
and modelling data, using the medium stiff microenvironment, showed approximately a 40% 233 
decrease in spheroid radii upon paclitaxel treatment. 234 
To validate the spheroid growth–inhibitory effects upon paclitaxel treatment, we used a 235 
spheroid–based intraperitoneal animal model. Paclitaxel administration significantly reduced 236 
tumour growth compared to non–treated controls with a response rate of 59% (Figure S5). 237 
238 
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Discussion 239 
 240 
In this study, we employed a bioengineered microenvironment, that mimics the fibrin clot 241 
providing the cancer cell niche during progression of ovarian cancer 23, using a combined 242 
experimental and mathematical modelling approach to analyse spheroid growth. Time–lapse 243 
imaging of 3D embedded cell cultures revealed that individual cancer cells can form 244 
multicellular spheroids within a bioengineered microenvironment whose mechanical 245 
properties are tunable. These experimental findings formed the basis for a mathematical 246 
model that quantitatively reproduced the proliferative and apoptotic behaviour of spheroids 247 
arising from the three different stiff microenvironments tested. Moreover, this 3D approach to 248 
cell biology has proven to quantitatively model the response of cancer spheroids to the 249 
clinically–administered anti–cancer agent paclitaxel, which was combined reproducible with 250 
our mathematical simulations contributing to its predictive power of cell–based drug 251 
screenings. Our first animal experiments are also consistent with the in vitro results in terms 252 
of spheroid–based tumour growth and responsiveness towards paclitaxel. 253 
 254 
Spheroid size in response to stiffness of microenvironment 255 
Our data indicate that microenvironmental stiffness affects spheroid size and expression of 256 
survival and apoptotic markers, results which are consistent with other studies. Cheng et al. 257 
showed that mechanical stress induced by the microenvironment can cause morphological 258 
changes in the in vitro growth of breast cancer cells, by inducing apoptosis in areas of high 259 
compressive stress and allowing proliferation in areas of low compressive stress 24. In the 260 
experiments reported here, ovarian cancer spheroids were smaller and more compact when 261 
grown in stiffer microenvironments, leading to low expression of apoptotic markers in the 262 
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spheroid periphery. Larger and less compact spheroids formed in softer microenvironments, 263 
resulting in strong expression of markers of cell proliferation and survival. 264 
We have reported that the proliferation rate of ovarian cancer spheroids was significantly 265 
increased when grown on both RGD–functionalised and non–RGD–functionalised hydrogels 266 
compared to cell monolayers. While fewer spheroids were formed in non–RGD–267 
functionalised hydrogels, the spheroid volume was not changed upon RGD–functionalisation 268 
3. Since not all integrin ligands bind via a RGD motif to their respective receptors, and the 269 
cancer spheroids generated in this study continued to proliferate when these cell–integrin 270 
binding sites were absent, we decided to use integrin α6 as a marker for cell proliferation and 271 
survival. Integrin α6 contributes not only to proliferation but also to cell–matrix interactions 272 
9. It is essential for the organization and maintenance of epithelial structures that form hemi–273 
desmosomes which link intermediate filaments with the ECM 25. Such cytoskeletal filaments 274 
were observed in our ultrastructural image analyses. Based on our previously reported results 275 
3, we used matrix metalloproteinases (MMP)–sensitive hydrogels throughout this study as we 276 
detected enhanced spheroid growth rates compared to MMP–insensitive hydrogels. 277 
The ability to use bioengineered approaches to culture cells in a 3D microenvironment that 278 
more accurately reproduces conditions in vivo is now creating a demand for new 279 
mathematical and computational models that can integrate experimental data about 280 
biomolecules, adhesive forces and signalling regulators, and quantify cellular responses 26-28. 281 
Various processes act in concert to initiate cancer spheroid formation. They may act across 282 
multiple length and time scales, involve heterogeneous cell populations and be regulated by 283 
biophysical and biochemical cues 29. Mathematical and computational models, with strong 284 
predictive power, are needed to unravel the ways in which these disparate processes regulate 285 
tumour growth in general, and ovarian cancer metastasis initiated by spheroid formation in 286 
particular. 287 
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Helmlinger et al. developed an empirical model to simulate the effects of solid stress on 288 
cancer cell proliferation, apoptosis and density using agarose gel cultures for up to 42 days 289 
using linear poroelastic simulations 30. Individual spheroids grew until a growth–inhibitory, 290 
threshold level of solid stress was reached 30. In line with both our experimental and 291 
theoretical results, an inverse correlation between matrix stiffness, spheroid growth and size 292 
was observed: the stiffer the microenvironment, the smaller spheroids were formed. While 293 
the experimental proliferation rate was not affected by solid stress, the apoptotic rate 294 
decreased and the cell density increased leading to the hypothesis that stress–induced 295 
inhibition of tumour growth may confer a survival advantage towards the formation of a solid 296 
tumour. These spheroid growth–inhibitory effects were not attributed to limitations in 297 
nutrient supply or waste removal. In the same study, it has also been shown that cell–cell 298 
contacts are associated with higher cell densities, thereby inhibiting apoptotic events and 299 
leading to drug resistance 30. 300 
The constraining effect of the microenvironment was incorporated in the IPM model by 301 
treating the hydrogel as a linearly elastic material and relating the pressure on the spheroid 302 
boundary to the degree of deformation of the surrounding matrix. This assumption meant that 303 
the force exerted on the microenvironment by the tumour can increase as the size of the 304 
spheroid increased. Additionally, stiffer microenvironments were predicted to give rise to 305 
smaller spheroids in the IPM model. 306 
 307 
Spheroid size in response to anti–cancer treatment 308 
In our experimental context, anti–cancer drug treatment induced morphological features of 309 
apoptosis like cell shrinkage and reduced spheroid radii. The administration of paclitaxel on 310 
day 7 of 3D culture was mathematically simulated by reducing the net growth rate coefficient 311 
15 
of the spheroids from the time of application. In line with our experiments, paclitaxel 312 
decreased spheroid radii in the mathematical simulations. 313 
Our experiments also revealed an increase in caspase–8 expression by the cancer spheroids 314 
with increasing mechanical properties of the microenvironment, culture time and drug 315 
treatment. Chen et al. showed that invasive carcinoma cells grown as tumour spheroids 316 
embedded in a deformable microenvironment also promote caspase–8–dependent apoptosis 317 
due to disruption of cell–ECM interactions 31. Interestingly, caspase–8 expression was 318 
detected in the outer region of spheroids grown for 14 days, suggesting the presence of dying 319 
cells in the spheroid periphery and proliferating cells towards the centre. When spheroids 320 
were cultured up to 28 days, caspase–8 and integrin α6 expression were detected throughout 321 
large spheroids suggesting concomitant and size–dependent expression of both proteins 322 
transmitting anti–apoptotic signalling, which might be attributed to the non–apoptotic role of 323 
caspase–8 caused by post–translational modifications due to cell–adhesions via integrins 32. 324 
In future work, the mathematical model will be extended to predict the spatio–temporal 325 
pattern of proliferative and apoptotic markers, including caspase–8 and integrins. 326 
In contrast to what was seen in agarose gels 30, when ovarian cancer spheroids were cultured 327 
in bioengineered microencironments for up to 28 days, the apoptotic level increased. In the 328 
same publication, Helmlinger et al. state that the growth of spheroids cultured in collagen 329 
gels was similarly inhibited. This result underscores the non–physiological nature of agarose 330 
gels, although these gels appear to enable spheroid formation of more aggressive tumour cell 331 
lines 33. Differences in material properties used to establish multicellular cancer spheroid 332 
cultures of various tumour cell lines are not easily integrated 33. Within our biomimetic 333 
hydrogel–based microenvironments minor apoptotic events were detectable after 14 days and 334 
became more pronounced in the spheroid centre after 28 days. In contrast, in spheroids 335 
cultured within agarose gels these apoptotic areas may be replaced by necrosis 24. Strikingly, 336 
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the overall cell area was significantly increased and size of the cell nuclei were enlarged in 337 
spheroids treated with low dosages of paclitaxel. Additionally, and in agreement with other 338 
reports 34,35, the nuclei of cells used in this study exhibited variable morphologies indicative 339 
of apoptotic events. 340 
 341 
Modelling the growth of multicellular cancer spheroids 342 
In this study, a simple mathematical model was developed to simulate the growth of 343 
multicellular spheroids within a bioengineered matrix that mimics the cancer cell niche 344 
during progressive ovarian cancer. A Markov Chain Monte Carlo algorithm was used to 345 
estimate the key model parameters including molecular and microscopic scales. 346 
Computational models of complex biomedical phenomena, such as tumour development and 347 
progression, are increasingly being used to shape our understanding of the mechanisms that 348 
underpin cancer biology. There has been a concerted effort to develop mathematical models 349 
of multicellular spheroids and avascular tumours, as reviewed by Araujo and McElwain 36, 350 
Roose et al. 33 and Byrne 12. Byrne and Drasdo 18 compared two different approaches to 351 
model multicellular spheroids: an individual cell–based model and a continuum model. 352 
Interestingly, a triphasic model of tissue growth 37 takes the ECM, tumour cells and 353 
extracellular liquid as the essential constituents. The role of stress in tumour development is 354 
important, and the inclusion of the evolution of stress within the growing spheroid represents 355 
an interesting and natural extension of the mathematical model presented here. 356 
 357 
Conclusions 358 
In summary, our data support the endeavours to drive the integration of 3D cell biology, 359 
mathematical sciences and bioengineering by providing a more realistic assessment and 3D 360 
communication network of the physiological relevant context of cancer using experimental 361 
17 
and mathematical modelling approaches. We have shown that increasing microenvironmental 362 
stiffness and exposure to an anti–cancer drug produced smaller spheroids due to increased 363 
apoptosis. Our mathematical model quantitatively captures the experimentally observed 364 
results. We anticipate that in future studies the mathematical model will be further developed 365 
to incorporate the effects of cancer treatment and chemotherapy resistance dependent on 366 
microenvironmental parameters. 367 
368 
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Figure Legends 392 
 393 
Figure 1. Cancer cell spheroid formation within hydrogels as a function of biomaterial 394 
stiffness. A. The growth and size of multicellular spheroids was dependent on a varying 395 
stiffnesses (elastic shear modulus G’ = 241 ± 19, 637 ± 93, 1201 ± 121 Pa) of bioengineered 396 
microenvironments depicted by hematoxylin (H)/eosin(E) staining (top panel) and maximal 397 
projections of CLSM images (bottom panel; cell actin filaments stained with rhodamine415–398 
conjugated phalloidin red, nuclei with DAPI blue). Large and less compact spheroids grew in 399 
less stiff (G’ = 241 ± 19 Pa), and smaller and compact spheroids were formed in stiff (G’ = 400 
1201 ± 121 Pa) microenvironments. Scale bars, 20 µm. B. Scanning electron micrographs 401 
confirm formation and growth of spheroids with increasing size in different stiff 402 
microenvironments over 14 days. Scale bars, 10 µm. C. The proliferation of multicellular 403 
spheroids, measured as fluorescence per hydrogel condition, was inversely associated with 404 
the biomaterial stiffness. Statistical significance, * – P<0.05, ** – P<0.01. D. Protein 405 
expression in less stiff microenvironments (G’ = 241 ± 19 Pa; left panel) was more 406 
pronounced regarding survival stimuli (integrin α6) in the centre and apoptotic (caspase–8) 407 
events in outer areas of large spheroids compared to stiff microenvironments (G’ = 1201 ± 408 
121 Pa; right panel; protein markers stained with respective primary and Alexa488–409 
conjugated secondary antibodies green). Scale bars, 50 µm. E. The total cell area of spheroids 410 
cultured within matrices of varying stiffness was calculated using Metamorph (integrated 411 
morphometry analysis). The spheroid area was inversely correlated with the biomaterial 412 
stiffness (increasing stiffness: soft (G’ = 241 ± 19 Pa) in blue, medium stiff (G’ = 637 ± 93 413 
Pa) in red and stiff (G’ = 1201 ± 121 Pa) in green). Statistical significance, ** – P<0.01, *** 414 
– P<0.001. F. Simulation of spheroid radius as a function of three different stiffnesses 415 
(increasing stiffness: soft (G’ = 241 ± 19 Pa) in blue, medium stiff (G’ = 637 ± 93 Pa) in red 416 
20 
and stiff (G’ = 1201 ± 121 Pa) in green over a defined period of time (5 days) using the IPM 417 
model. This model predicted that higher biomaterial stiffness results in smaller spheroid radii. 418 
 419 
Figure 2. Protein expression dependent on size and culture time of cancer cell spheroids 420 
grown within hydrogels. A. Multicellular spheroids grown within bioengineered 421 
microenvironments [medium stiff (G’ = 637 ± 93 Pa)] for 14 (left panel) and 28 (right panel) 422 
days illustrated by H/E staining (top panel) and maximal projections of CLSM images 423 
(bottom panel). H/E staining was stronger after 28 days in the outer regions of large spheroids 424 
(radii 70 ± 6 µm). Spheroids formed after 14 days (radii 38 ± 4 µm) showed a distinctive 425 
integrin α6 staining pattern in the spheroid centre and negligible caspase–8 staining. Larger 426 
spheroids grown after 28 days revealed strong integrin α6 staining throughout the spheroid 427 
and some caspase–8 staining scattered in the spheroid centre. Scale bars, 25 µm. B. The 428 
proliferation of multicellular spheroids, measured as fluorescence per sample, was associated 429 
with the culture time and significantly increasing over 28 days. Statistical significance, ** – 430 
P<0.01. C. The total cell area of spheroids cultured within hydrogels for 14 and 28 days 431 
respectively was calculated using Metamorph (integrated morphometry analysis). The 432 
spheroid area was significantly increased after 28 days in 3D culture compared to 14 days. 433 
Statistical significance, *** – P<0.001. D. Simulation of spheroid radius as a function of 434 
culture time (60 days) using the IPM model, with spheroid radii increasing from 45 µm (at 14 435 
days) to 67 µm (at 28 days). 436 
 437 
Figure 3. Behaviour of cancer cell spheroids within hydrogels upon treatment with the 438 
anti–cancer drug paclitaxel. A. Multicellular spheroids grown within bioengineered 439 
microenvironments [medium stiff (G’ = 637 ± 93 Pa)] for 14 days without (left panel) or with 440 
(right panel) treatment with paclitaxel represented by H/E staining (top panel) and maximal 441 
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projections of CLSM images (bottom panel). Upon paclitaxel treatment smaller spheroids 442 
were formed (radii 23 ± 3 µm) compared to non–treated samples (radii 37 ± 5 µm). Whereas 443 
minor survival stimuli (integrin α6) and increased apoptotic events (caspase–8) were detected 444 
after treatment with paclitaxel, a strong integrin α6 expression throughout the spheroid and 445 
no caspase–8 expression were visualized without treatment. Scale bars, 25 µm. B. The 446 
proliferation of multicellular spheroids, measured as fluorescence per hydrogel condition, 447 
was decreased significantly upon paclitaxel treatment. Statistical significance, ** – P<0.01. 448 
C. The total spheroid area (i) as well as the single cell area (ii) and area of nuclei (iii) of cells 449 
grown within a multicellular spheroid were calculated using Metamorph (integrated 450 
morphometry analysis). Upon treatment with paclitaxel, the total spheroid area decreased 451 
significantly, the single cell area increased significantly and larger nuclei were formed. 452 
Statistical significance, ** – P<0.01. D. Transmission electron micrographs showed 453 
morphological differences of cell spheroids after treatment: without treatment defined cell 454 
structures within spheroids were visible, after treatment necrotic areas and smaller cell 455 
spheroids were detected (AJ–tight junction, CF–cytoskeletal filaments, ER–endoplasmatic 456 
reticulum, GA–golgi apparatus, M–mitochondria, N–nucleus, NEC–necrotic cell). Scale bars, 457 
overview – 1 µm, zoom – 0.2 µm. E. Simulation of spheroid radius without treatment (shown 458 
in red) and after treatment (shown in blue) using the IPM model in the medium stiff (G’ = 459 
637 ± 93 Pa; i) microenvironments, with a growth of the spheroid radii over a time from 460 
0t   to time 14t   days to 37 µm. Upon treatment at day 7 of spheroid growth, spheroid 461 
radii of 23 µm were reduced over the time of simulation (i). The spheroid radii were also 462 
simulated in the soft (G’ = 241 ± 19 Pa; ii) and stiff (G’ = 1201 ± 121 Pa; iii) 463 
microenvironments with and without treatment. 464 
 465 
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Figure S1. Proliferative and apoptotic protein expression of cancer cell spheroids grown 466 
within medium stiff (G’ = 637 ± 93 Pa) hydrogels. Expression of proliferation (Ki67, 467 
integrin α6) and apoptosis (caspase–8) markers of multicellular spheroids were analysed 468 
performing maximal projections of CLSM images. A distinct Ki67 staining of a cell 469 
undergoing division and transmembrane integrin α6 staining were detected, while 470 
cytoplasmic caspase–8 staining was more pronounced at the outer spheroid area. Scale bars, 5 471 
µm. 472 
 473 
Figure S2. Cancer cell spheroid formation within hydrogels as a function of biomaterial 474 
stiffness. A. Maximal projections of CLSM images depicted that protein expression in less 475 
stiff (G’ = 241 ± 19 Pa) microenvironments was more pronounced regarding survival stimuli 476 
(Ki67) in the centre and apoptotic (annexin V, caspase–8) events in outer areas of large 477 
spheroids. Scale bars, 50 µm B. Protein expression in stiff (G’ = 1201 ± 121 Pa) 478 
microenvironments was reflected by weak staining of proliferative (Ki67) and apoptotic 479 
(annexin V, caspase–8) markers using maximal projections of CLSM images. Scale bars, 50 480 
µm. 481 
 482 
Figure S3. Time–lapse microscopy of spheroid formation dependent on biomaterial 483 
stiffness. Time–lapse microscopy of live cell spheroid survival and formation in soft (G’ = 484 
241 ± 19 Pa), medium stiff (G’ = 637 ± 93 Pa) and stiff (G’ = 1201 ± 121 Pa) 485 
microenvironments over 4.5 days showed that multicellular spheroids were formed from 486 
single cells (supplementary movies). Scale bars, overview – 100 μm, zoom – 50 μm. 487 
 488 
Figure S4. Time–lapse microscopy of spheroid formation dependent on biomaterial 489 
stiffness. Representative time–lapse experiments (avi–files) of spheroids grown within 490 
23 
different stiff (elastic shear modulus G’ = 241 ± 19, 637 ± 93, 1201 ± 121 Pa) hydrogels are 491 
shown using a widefield microscope over a time frame of 4.5 days with images taken every 492 
20 min with a 10x air objective. 493 
 494 
Figure S5. Spheroid–based ovarian cancer mouse model using medium stiff (G’ = 637 ± 495 
93 Pa) hydrogels. A. All intraperitoneal organs, including tumours, were weighted after 4 496 
and 8 weeks respectively (green blots) and paclitaxel treatment in week 4 for another 4 weeks 497 
(red blot). Then, the visible tumour mass was removed and weighed separately indicated as 498 
ratio between tumour weight and total weight. Spheroid–induced tumour growth was 499 
significantly enhanced after 8 weeks compared to 4 weeks (p=0.00015). Paclitaxel treatment 500 
significantly reduced tumour growth compared to non–treated controls (p=0.002). B. H/E 501 
immunohistochemistry confirmed tumour formation and presence of spheroids within 502 
hydrogels after in vivo implantation: a) tumour mass and b) spheroid after 4 weeks of in vivo 503 
growth; c) tumour mass and d) spheroid after 8 weeks of in vivo growth; e) tumour mass and 504 
f) spheroid after paclitaxel treatment. Scale bars, 25 µm. 505 
506 
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Supplementary Methods 598 
 599 
Materials. Cell culture reagents, rhodamine415–conjugated phalloidin, Alexa488–600 
conjugated anti–mouse/rabbit IgG, 4'–6–diamidino–2–phenylindole, CyQuant, proteinaseK 601 
and ProLong Gold anti–fade reagent were from Invitrogen. Paraformaldhyde, bovine serum 602 
albumin and paclitaxel were from Sigma–Aldrich. Polyclonal antibodies anti–annexin V, 603 
anti–Ki67, anti–capase–8 and the monoclonal antibody anti–caspase–3 (#E87) were from 604 
Abcam. The monoclonal antibody anti–α6–integrin (#4F10) was from Chemicon. Triton X–605 
100 was from Calbiochem. TissueTek embedding media and glass coverslips were from 606 
ProSciTech. 607 
 608 
Three–dimensional cell cultures. Preparation of synthetic hydrogel biomaterials that are 609 
formed from peptide–functionalised multiarm polyethylene glycol (PEG) macromolecules via 610 
the factor XIII–catalysed cross–linking mechanism, a reaction occurring during fibrin clot 611 
formation in natural wound healing, was conducted as reported previously 13. Simultaneously 612 
with the hydrogel formation, the RGD integrin–binding motif and a specific cleavage 613 
sequence for cell–secreted/activated matrix metalloproteinases (MMP) were incorporated. 614 
The matrix stiffness was regulated by changing the polymer dry mass of the hydrogel, 615 
without changing its biological and biochemical characteristics conferring biomimetic 616 
features. The human epithelial ovarian carcinoma cell line OV–MZ–6 was established from 617 
malignant ascites and cultured as described earlier 22. For three–dimensional (3D) cell 618 
cultures, ovarian cancer cells were encapsulated within PEG–based hydrogel precursor 619 
solution and cultured for up to 28 days to form multicellular spheroids. For exposure to 620 
paclitaxel, cancer cell spheroids were grown for 7 days and then treated with paclitaxel (10 621 
nmol/L) for another 7 days 3. Cell spheroids were washed in phosphate–buffered saline 622 
29 
(PBS), fixed with 4% (w/v) paraformaldehyde (PFA)/PBS for 20 min at room temperature 623 
(RT), embedded in 50% (v/v) TissueTek/PBS for 40 min at RT, replaced by 100% (v/v) 624 
TissueTek for 40 min at RT, frozen in liquid nitrogen and stored at –80ºC until cryo–625 
sectioned (5–7 µm) at the Joint Histo–technology Facility of the University of Queensland 626 
and Queensland Institute for Medical Research. 627 
 628 
Cell proliferation assays. The growth of multicellular spheroids within PEG–based 629 
hydrogels was measured performing CyQuant assays as reported before 3. CyQuant assays 630 
and respective fluorescence signals were used to quantify the DNA content per hydrogel 631 
condition. Three different proliferation assays were conducted in triplicate. 632 
 633 
H/E staining. Staining of nuclei with hematoxylin (H) and the cytoplasm with eosin (E) was 634 
carried out at the Joint Histo–technology Facility of the University of Queensland and 635 
Queensland Institute for Medical Research using standard operation procedures. Photographs 636 
were taken using a widefield microscope (LaborLux, Leitz; DXM1200C digital camera with 637 
respective ACT–1C software version 1.01, Nikon) with a 40x air objective. 638 
 639 
Confocal laser scanning microscopy. After 14 and 28 days respectively, F–actin filaments, 640 
nuclei and specific cell vitality markers were immunofluorescently stained and imaged by 641 
confocal laser scanning microscopy (CLSM). Sections were permeabilised with 0.2% (v/v) 642 
triton X–100/PBS for 15 min at RT. Following two washes in PBS, sections were blocked 643 
with 1% (w/v) bovine serum albumin (BSA)/PBS for 2 hr at RT. Then, primary (proliferation 644 
markers: Ki67 (1/250), integrin α6 (1/50); apoptotic markers: annexin V (1/250), caspase–8 645 
(1/50), caspase–3 (1/50)) and secondary (Alexa488–conjugated anti–mouse/rabbit IgG 646 
(1/1,000)) antibodies in 1% (w/v) BSA/PBS were incubated each for 1 hr at RT. The 647 
30 
secondary antibody only served as a negative control. F–actin filaments and nuclei were 648 
stained with 0.3 U/mL rhodamine415–conjugated phalloidin and 2.0 µg/mL DAPI 649 
respectively in 1% (w/v) BSA/PBS. Sections were mounted with ProLong Gold anti–fade 650 
reagent and a glass coverslip. Immunofluorescence was visualized and photographed using a 651 
confocal microscope (TCS SP5 II, Leica) with a 20x immersion oil objective. Z–stacks were 652 
acquired with a constant slice thickness of 0.5 µm reconstructing a cross–section profile of 5 653 
µm using the Leica Microsystems LAS AF software (version 1.8.2 build 1465) to generate 654 
maximal projections. 655 
 656 
Calculation of cell area. For overall cell area and nuclei calculations, the integrated 657 
morphometry analysis tool in Metamorph (version 7.6.0.0) was used to trace the total 658 
spheroid area, the area of single cells within a spheroid and the area of single nuclei using 659 
either the phalloidin–stained actin filaments or the DAPI–stained nuclei. Maximal projections 660 
using separate channels of CLSM images were arithmetic processed, set to auto–threshold 661 
and gray levels binarized. An integrated morphometry analysis was performed to calculate 662 
the marked area either of the overall cell area or the nucleus. Averages and standard errors 663 
were calculated using Excel (Microsoft, Redmond, WA). For each experiment, 5 sections and 664 
up to 10 spheroids, single cells or nuclei per spheroid were analysed. For calculation of cell 665 
nuclei after paclitaxel treatment, only intact non–lysed cells (without the appearance of 666 
apoptotic bodies) were taken into account. 667 
 668 
Scanning electron, transmission electron and time–lapse microscopy. After 14 days of 3D 669 
culture, samples were prepared for scanning and transmission electron microscopy as 670 
described earlier 3 in order to visualize spheroid morphology and ultra–structures. Time–lapse 671 
microscopy of 3D cultures was performed as reported previously 3 to live image spheroid 672 
31 
formation and survival. Samples were imaged using a widefield microscope (Leica, AF6000 673 
LX) under sterile humidified atmosphere at 37 °C/5% (v/v) CO2 over 4.5 days with images 674 
taken every 20 min with a 10x air objective. Spheroids grown within different stiff (elastic 675 
shear modulus G’ = 241 ± 19, 637 ± 93, 1201 ± 121 Pa) hydrogels were visualized at five 676 
different positions and the experiment conducted in triplicate. 677 
 678 
Spheroid–based ovarian cancer mouse model. Animal experiments were in compliance 679 
with the Australian Code of Practise for the Care and Use of Animals for Scientific Purposes 680 
and approved by the University Animal Ethics Committee. 3D cultures were prepared as 681 
above, and spheroids grown for 2 weeks within medium stiff (G’ = 637 ± 93 Pa) hydrogels 682 
before implantation into 6 weeks old, female NOD/SCID mice. Animals received spheroid–683 
containing hydrogel implants adjacent to both ovaries and the abdominal fat pad (6 684 
animals/group) and were monitored weekly until the predetermined endpoint (8 weeks) was 685 
reached. After 4 weeks of tumour growth, animals were treated with paclitaxel (10 mg/kg) 686 
twice/week over 4 weeks. After 8 weeks, animals were sacrifieced, tumour tissues and 687 
hydrogels removed, weighed and processed for serial sectioning (section thickness, 5 μm) for 688 
immunohistochemistry and H/E staining. 689 
 690 
Statistics. Statistical analyses were carried out using a Student’s t–test and ANOVA with 691 
Bonferroni correction with ‘R’ (version 2.10.0). Results with a p–value less than 0.05 were 692 
considered to be statistically significant (* – P<0.05; ** – P<0.01; *** – P<0.001). 693 
 694 
Mathematical model. Appealing to the law of mass conservation, the cell velocity can be 695 
related to the local growth rate 696 
 · ( , , )v g r t p   (6) 697 
32 
where ( , , )g r t p  is the net local growth rate (proliferation minus apoptosis), p  is the pressure 698 
of the ‘cellular fluid’, and r  is the spatial variable (radius). Cell movement was assumed to 699 
be governed by Darcy’s Law 700 
 v k p    (7) 701 
where k  represents the ratio of the permeability and the dynamic viscosity. Equations (6) and 702 
(7) gave 703 
 2 ( , , ).k p g r t p    (8) 704 
Under the assumption of spherical symmetry equation (8) becomes 705 
 22
1 .p gr
r r r k
         (9) 706 
The growth function, g , was decomposed into two components 707 
 p ag g g   708 
where pg  and ag  are the proliferation and apoptosis rates, respectively. Based on the 709 
experimental observation that the proliferation rate appeared to be lower in stiffer hydrogels 710 
(see integrin profiles in Figures 1D, S2B), where the local pressure in the spheroid will be 711 
higher, the following proliferation rate was adopted 712 
 g p  s1m  s2m p,  (10) 713 
where s1
m  and s2
m  are constants. Based on the experimental observation that in softer 714 
hydrogels, where the local pressure will be lower, was a more pronounced apoptotic signal 715 
(see caspase profiles in Figures 1D, S2A), we adopted 716 
 ga  s1a  s2a p, (11) 717 
where s1
a and s2
a are constants. More complex functional forms for pg  and ag  can be 718 
investigated, but here the simplest form that captures the experimental observations was 719 
employed. The growth function is therefore given by 720 
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g  g p  ga  (s1m  s1a )  (s2m  s2a ) p  s1  s2 p . 721 
where s1  s1m  s1a  and s2  s2m  s2a  are constants. We refer to s1  and s2 as the net growth rate 722 
coefficient and the net growth rate linear coefficient, respectively. Combining equations (9) 723 
to (11) supplied the following differential equation for pressure within the tumour mass 724 
 2 1 22
( )1 .s s ppr
r r r k
         (12) 725 
The outer spheroid radius ( )R t  was assumed to move with the local cell velocity 726 
 ( ( .), )
r R
dR pv R t t k
dt r 
     (13) 727 
The system was closed by imposing that 
0
0
r
p
r 
   and that the cell pressure balances the 728 
restraining force exerted on the growing tumour by the hydrogel on ( )r R t . Rather than 729 
explicitly modelling the hydrogel (see Chen et al. for a discussion of how this can be done 31), 730 
it was viewed as a linearly elastic solid and the restraining force, that it exerts on the tumour, 731 
was assumed to be proportional to the displacement of material points on the boundary from 732 
their initial location, so that 733 
 0
0
( ( )) 4 ( ( ) ),p R t R t R
R
   (14) 734 
where 0R  is the initial spheroid size and   the shear modulus of the hydrogel. Further 735 
justification for using equation (9) can be obtained by considering the classical problem of a 736 
rigid spherical inclusion in an elastic medium 38. 737 
 738 
Mathematical model analysis. The pressure ( , )p r t  was determined by integrating equation 739 
(12) subject to the boundary conditions at 0r   and ( )R t  to obtain 740 
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sinh
( , ) ( ) .
s r
k sp r t A t
r s
      (15) 741 
In equation (15), A(t) was determined from the surface boundary condition, giving 742 
 10
2 2
( )( ) ( ( ) ) .
sinh ( )
s R tA t R t R
s s R t
k
          
 (16) 743 
Substituting (15) and (16) in equation (13) supplied the following ordinary differential 744 
equation (ODE) for the spheroid radius ( )R t  745 
 
2 2
1
0
2
( ) coth ( ) 1
( ) ( ( ) ) ,
( )
s sR t R t
k ksdR t k R t R
dt s R t

                 
 (17) 746 
where 
0
4
R
  . For more general choices of g , a full numerical solution of equations (12) 747 
and (13) must be computed. 748 
 749 
Parameter estimation. Uninformative priors over regions of reasonable parameter values 750 
were specified for the parameters 0 1 2 0 1 2 3, , , , , ,s s s R    (collectively, denoted  ). The 751 
likelihood ( ( )f R  ) of the experimental observations of the spheroid radius, , 1iR i N  , 752 
(where N  is the number of observations) given the parameter values ( ) was taken to be a 753 
normal likelihood function, with a mean given by the solution to equation (5). The 754 
distribution of the growth parameters, given the experimental data, ( )f R  was estimated 755 
using a Markov Chain Monte Carlo algorithm, implemented within the PyMC framework 39. 756 
